» Articles » PMID: 38585491

Asian Herbal Medicine for Atopic Dermatitis: a Systematic Review

Overview
Publisher PagePress
Specialty Dermatology
Date 2024 Apr 8
PMID 38585491
Authors
Affiliations
Soon will be listed here.
Abstract

Asian herbal medicines have been known for decades, and some have been used to treat atopic dermatitis (AD). This chronic and persistent inflammatory skin condition causes severe morbidity and negatively impacts the quality of life. In numerous trials, traditional Chinese medicines have demonstrated clinical efficacy for AD. However, there is no well-documented summary of the wide variety of Asian herbal medicines used in treating AD. We aimed to systematically summarize the use of Asian herbal medicine in AD. An English-language literature search was performed in three electronic medical databases: PubMed, Cochrane Library, and EBSCOhost using keywords [("atopic dermatitis" OR "atopic eczema") AND ("traditional" OR "herbal")] and limited to references published between January 2015 and December 2022. The literature included newborns, infants, children, adolescents, and adults. The review was conducted using the extension to determine the main criteria. The content and inclusiveness of the search were filtered using relevant terms (MeSH/Emtree), keywords, titles, and abstracts. Thirteen articles (12 randomized clinical trial + 1 clinical trial) reported a variety of herbal medicine compounds to treat AD with various efficacy. Most studies reported significant improvement when comparing the herbal medicine with a placebo, but only 1 study reported substantial improvement of SCORAD compared to corticosteroids. Asian herbal medicines have been studied and may be used as an alternative treatment in treating AD with fewer adverse effects. However, its role did not change the position of standard treatment in treating atopic dermatitis.

References
1.
Meysami M, Hashempur M, Kamalinejad M, Emtiazy M . Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Endocr Metab Immune Disord Drug Targets. 2020; 21(9):1673-1678. DOI: 10.2174/1871530320666201023125411. View

2.
Chow S, Seow C, Dizon M, Godse K, Foong H, Chan V . A clinician's reference guide for the management of atopic dermatitis in Asians. Asia Pac Allergy. 2018; 8(4):e41. PMC: 6209602. DOI: 10.5415/apallergy.2018.8.e41. View

3.
Tsakok T, Woolf R, Smith C, Weidinger S, Flohr C . Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2018; 180(3):464-474. DOI: 10.1111/bjd.16934. View

4.
Bhanegaonkar A, Horodniceanu E, Ji X, Detzel P, Botteman M . Burden of Atopic Dermatitis in Indonesia, Malaysia, and Singapore: Estimates from a Mathematical Model. Value Health. 2016; 17(7):A778. DOI: 10.1016/j.jval.2014.08.359. View

5.
Vinding G, Zarchi K, Ibler K, Miller I, Ellervik C, Jemec G . Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm Venereol. 2013; 94(4):480-2. DOI: 10.2340/00015555-1761. View